Pozen Sues Par Pharmaceutical Over Migraine ANDA
Pozen Inc., a North Carolina-based pharmaceutical company specializing in pain medication, has sued Par Pharmaceutical Inc., for seeking regulatory approval of a generic version of Pozen's patented migraine treatment Treximet....To view the full article, register now.
Already a subscriber? Click here to view full article